Abraham N Betre, DO
Obstetrics/Gynecology · Tulare
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 8
- Since medical school
- 28 years
- New York College of Osteo Medicine of New York Institute of Technology, 1998
Offices
8 locations · Altura Centers for Health · Saint Agnes Medical Foundation
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Betre’s office to ask if they take your plan before you enroll.
Medicaid work
$155,648 in 2024
Medicaid paid $155,648 for 6,394 billed services this clinician did in 2024, up to 102 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 951 | $119,705 |
| Prenatal care, at-risk enhanced service; antepartum management | 705 | $24,181 |
| OBSTETRICAL CARE | 27 | $5,865 |
| Short return visit (20+ min) | 444 | $4,669 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 1,234 | $679 |
| Postpartum care only (separate procedure) | 12 | $423 |
| URINE PREGNANCY TEST | 93 | $115 |
| HEMOGLOBIN | 13 | $10 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 1,093 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 48 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 1,028 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 91 | $0 |
| 2024 | 6,394 | 13 | 102 | $155,648 |
| 2023 | 6,880 | 20 | 92 | $250,778 |
| 2022 | 8,724 | 21 | 140 | $347,012 |
| 2021 | 9,665 | 20 | 155 | $416,800 |
| 2020 | 8,631 | 19 | 130 | $344,638 |
| 2019 | 6,684 | 14 | 180 | $328,432 |
| 2018 | 7,697 | 23 | 225 | $387,801 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,233 | $141,529 |
| Prenatal care, at-risk enhanced service; antepartum management | 1,529 | $51,216 |
| OBSTETRICAL CARE | 143 | $34,826 |
| Short return visit (20+ min) | 746 | $10,380 |
| Return visit (30+ min) | 335 | $5,354 |
| Cesarean delivery | 12 | $4,200 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 12 | $1,164 |
| New patient visit (45+ min) | 30 | $754 |
| Short return visit | 42 | $450 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 1,111 | $378 |
| Postpartum care only (separate procedure) | 13 | $242 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 21 | $181 |
2022
| Clinic visit/encounter, all-inclusive | 1,608 | $186,531 |
| Prenatal care, at-risk enhanced service; antepartum management | 1,910 | $63,068 |
| OBSTETRICAL CARE | 232 | $57,947 |
| Short return visit (20+ min) | 1,022 | $18,252 |
| Return visit (30+ min) | 427 | $6,645 |
| Cesarean delivery | 14 | $4,848 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 67 | $4,117 |
| New patient visit (45+ min) | 46 | $1,685 |
| 1ST HOSP IP/OBS HIGH 75 | 30 | $1,315 |
| Postpartum care only (separate procedure) | 37 | $1,192 |
| Short return visit | 60 | $691 |
| Prenatal care, at-risk assessment | 14 | $379 |
2021
| Clinic visit/encounter, all-inclusive | 2,232 | $246,907 |
| OBSTETRICAL CARE | 227 | $67,376 |
| Prenatal care, at-risk enhanced service; antepartum management | 1,764 | $54,177 |
| Short return visit (20+ min) | 1,407 | $32,515 |
| Cesarean delivery | 33 | $8,191 |
| Return visit (30+ min) | 178 | $4,842 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 13 | $1,295 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 1,432 | $1,064 |
| Short return visit | 28 | $325 |
| URINE PREGNANCY TEST | 322 | $106 |
| HEMOGLOBIN | 25 | $2 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 254 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,997 | $191,493 |
| OBSTETRICAL CARE | 191 | $53,859 |
| Prenatal care, at-risk enhanced service; antepartum management | 1,431 | $52,462 |
| Short return visit (20+ min) | 1,385 | $26,665 |
| Cesarean delivery | 39 | $11,147 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 55 | $4,803 |
| Return visit (30+ min) | 156 | $3,289 |
| Short return visit | 43 | $602 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 452 | $217 |
| URINE PREGNANCY TEST | 255 | $76 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 947 | $24 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 315 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 2,281 | $222,422 |
| OBSTETRICAL CARE | 136 | $40,158 |
| Prenatal care, at-risk enhanced service; antepartum management | 445 | $22,659 |
| Short return visit (20+ min) | 1,040 | $19,321 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 951 | $14,055 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 887 | $6,089 |
| Return visit (30+ min) | 100 | $2,152 |
| URINE PREGNANCY TEST | 222 | $643 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 14 | $574 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 100 | $136 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 13 | $106 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 75 | $86 |
2018
| Clinic visit/encounter, all-inclusive | 3,036 | $297,019 |
| Short return visit (20+ min) | 1,066 | $24,970 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 1,432 | $23,120 |
| OBSTETRICAL CARE | 78 | $19,057 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 1,039 | $9,132 |
| URINE PREGNANCY TEST | 430 | $4,763 |
| Service | 17 | $2,361 |
| Cesarean delivery | 14 | $2,179 |
| 1ST HOSP IP/OBS HIGH 75 | 19 | $1,570 |
| Return visit (30+ min) | 67 | $970 |
| Short return visit | 39 | $608 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 112 | $369 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 68 Part D prescriptions in 2023.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2023 | 68 | 22 | 0% (0) | 16% | $4,458 |
| 2022 | 98 | 32 | 0% (0) | 22% | $8,501 |
| 2021 | 107 | 28 | None | 27% | $8,607 |
| 2020 | 100 | 29 | None | 31% | $15,101 |
| 2019 | 72 | 28 | 0% (0) | 19% | $5,814 |
| 2018 | 83 | 31 | None | 22% | $6,974 |
| 2017 | 107 | 39 | None | 30% | $10,181 |
| 2016 | 135 | 47 | None | 31% | $9,592 |
| 2015 | 187 | 65 | None | 37% | $16,756 |
| 2014 | 148 | 41 | 14% (20) | None | $8,640 |
| 2013 | 144 | 41 | 9% (13) | None | $9,946 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Estradiol | 24 | $739 | $31 |
2022: 3 drugs
| Prempro | 11 | $2,676 | $243 |
| Estradiol | 34 | $1,313 | $39 |
| Medroxyprogesterone Acetate | 15 | $201 | $13 |
2021: 3 drugs
| Prempro | 16 | $3,631 | $227 |
| Estradiol | 32 | $581 | $18 |
| Medroxyprogesterone Acetate | 17 | $218 | $13 |
2020: 3 drugs
| Prempro | 14 | $2,946 | $210 |
| Oxybutynin Chloride | 16 | $155 | $10 |
| Estradiol | 17 | $77 | $5 |
2019: 3 drugs
| Premarin | 11 | $3,915 | $356 |
| Oxybutynin Chloride | 15 | $358 | $24 |
| Estradiol | 15 | $70 | $5 |
2018: 1 drug
| Premarin | 15 | $5,253 | $350 |
2017: 2 drugs
| Premarin | 21 | $4,896 | $233 |
| Sertraline | 13 | $89 | $7 |
2016: 2 drugs
| Premarin | 19 | $4,435 | $233 |
| Paroxetine | 13 | $43 | $3 |
2015: 3 drugs
| Premarin | 35 | $9,540 | $273 |
| Levothyroxine | 13 | $148 | $11 |
| Atenolol | 13 | $35 | $3 |
2014: 5 drugs
| Premarin | 17 | $2,955 | $174 |
| Vesicare | 11 | $2,456 | $223 |
| Levothyroxine | 12 | $123 | $10 |
| Escitalopram | 12 | $93 | $8 |
| Atenolol | 12 | $41 | $3 |
2013: 4 drugs
| Premarin | 16 | $1,791 | $112 |
| Prempro | 13 | $1,244 | $96 |
| Levothyroxine | 12 | $99 | $8 |
| Atenolol | 12 | $46 | $4 |
Money from drug and device companies
$287 in 2025
| 2025 | 10 | 15 | None | $287 |
| 2024 | 9 | 13 | None | $317 |
| 2023 | 4 | 7 | None | $156 |
| 2022 | 6 | 24 | None | $1,309 |
| 2021 | 6 | 27 | None | $549 |
| 2020 | 3 | 9 | None | $232 |
| 2019 | 2 | 11 | None | $199 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
Alafair Biosciences, Inc.
$176,227
Held by this doctor · 2025, 2024, 2023 · Preferred Stock
Published ownership or investment in a drug or device company. This is not proof that care is biased.
A payment is not proof that care is biased.
| Sage Therapeutics | Zurzuvae | $61 | 3 payments
|
| Shield Therapeutics | Accrufer | $39 | 2 payments
|
| Astellas Pharma US | Veozah | $33 | 2 payments
|
| Organon | Nexplanon | $29 | 2 payments
|
| Hologic Sales and Service | Thinprep 2000 Processor | $23 | 1 payment
|
| Mayne Pharma Commercial | None | $22 | 1 payment
|
See all 15 published payments
| Shield Therapeutics | Meals · 2025-12-18 | Accrufer | $23 |
| Sage Therapeutics | Meals · 2025-12-17 | Zurzuvae | $19 |
| Sage Therapeutics | Meals · 2025-12-10 | Zurzuvae | $20 |
| Astellas Pharma US | Meals · 2025-10-21 | Veozah | $18 |
| Organon | Meals · 2025-09-09 | Nexplanon | $14 |
| Sumitomo Pharma America | Meals · 2025-08-19 | Myfembree | $20 |
| Merck Sharp & Dohme | Meals · 2025-08-12 | Gardasil 9 | $21 |
| Astellas Pharma US | Meals · 2025-07-17 | Veozah | $15 |
| Shield Therapeutics | Meals · 2025-07-09 | Accrufer | $16 |
| Mayne Pharma Commercial | Meals · 2025-06-19 | None | $22 |
| CooperSurgical | Meals · 2025-06-10 | Paragard T 380a | $22 |
| Hologic Sales and Service | Meals · 2025-05-21 | Thinprep 2000 Processor | $23 |
| Organon | Meals · 2025-04-28 | Nexplanon | $15 |
| Sage Therapeutics | Meals · 2025-03-11 | Zurzuvae | $22 |
| Dexcom | Meals · 2025-02-05 | Dexcom G6 Transmitter | $17 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $317
| Axonics | Axonics | $97 | 2 payments
|
| Sage Therapeutics | Zurzuvae | $51 | 3 payments
|
| Dexcom | Dexcom G6 Transmitter | $35 | 1 payment
|
| Sumitomo Pharma America | Myfembree | $31 | 2 payments
|
| Astellas Pharma US | Veozah | $31 | 1 payment
|
| Hologic Sales and Service | Aptima | $28 | 1 payment
|
| Abbvie | Ubrelvy | $18 | 1 payment
|
| Pfizer | Myfembree | $15 | 1 payment
|
| Organon | Jada System | $11 | 1 payment
|
2023: $156
| AbbVie | Orilissa | $101 | 4 payments
|
| Pfizer | Premarin | $22 | 1 payment
|
| Organon | Nexplanon | $17 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Mirena | $16 | 1 payment
|
2022: $1,309
| Axonics | Axonics | $976 | 7 payments
|
| Abbvie | Oriahnn | $162 | 7 payments
|
| TherapeuticsMD | Annovera | $94 | 5 payments
|
| Pfizer | Premarin | $44 | 3 payments
|
| Hologic | Acessa Provu System | $24 | 1 payment
|
| Organon | Nexplanon | $8 | 1 payment
|
2021: $549
| AbbVie | Oriahnn | $245 | 14 payments
|
| TherapeuticsMD | Annovera | $120 | 8 payments
|
| Mayne Pharma | None | $119 | 1 payment
|
| Pfizer | Premarin | $36 | 2 payments
|
| AMAG Pharmaceuticals | Makena | $16 | 1 payment
|
| Hologic | Acessa Provu System | $14 | 1 payment
|
2020: $232
| AbbVie | Orilissa | $152 | 5 payments
|
| TherapeuticsMD | Annovera | $56 | 3 payments
|
| Gilead Sciences | None | $25 | 1 payment
|
2019: $199
| AbbVie | Orilissa | $173 | 8 payments
|
| Hologic | Novasure | $26 | 3 payments
|
Professional record
- NPI
- 1053386565
- Licence
- CA 20A10290
- Trained
- New York College of Osteo Medicine of New York Institute of Technology, 1998 · 28 years ago
- Group
- Altura Centers for Health · Saint Agnes Medical Foundation
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 1134 E Cartmill Ave, Tulare, CA, 93274
- NPI first listed
- 2006-02-19
- NPI last updated
- 2026-01-05
- NPI record certified
- 2026-01-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1303 E Herndon Ave, Fresno, CA, 93720